In conclusion, this study demonstrated that NLRP4 enhances DNA repair capability and promotes ROS-induced autophagy under both basal conditions and treatment with olaparib, thereby leading to the development of olaparib resistance in pancreatic cancer cells both in vitro and in vivo. The gene discussed is NLRP4; the disease is familial pancreatic carcinoma.